$NXPL Cashflow Statement | Understand Stock

$NXPL

$8.50 -$0.12 (1.39%) Close

$NXPL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss
Cash received from revenue
E-Commerce
Healthcare Operations
Cash received from interest income
Cash received from other sources
Cash paid for inventory purchases and other costs of revenue
Cash paid for salaries and related expenses
Cash paid for other recurring operating expenses
Cash paid for other non-recurring expenses and merger costs
Cash paid for interest expense
Business combination without transfer of consideration
Cash paid for income taxes
Beneficial conversion feature on convertible debt
Issuance of common stock from convertible debt
Net cash used in operating activities

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment
Healthcare Operations
Total purchase of property and equipment
Capital contributions to equity method investee
Purchase of Netherlands subsidiary
Proceeds from sale or disposal of property and equipment
Cash acquired in acquisition of Outfitter Satellite subsidiary
Progressive Care
Outfitter Satellite, Inc.
Total cash acquired in acquisition of Outfitter Satellite subsidiary
Cash paid in acquisition of Outfitter Satellite subsidiary
Net cash provided by (used in) investing activities

CASH FLOWS FROM FINANCING ACTIVITIES:
Repayments of note payable, related party, net
Proceeds from (repayments to) note payable Coronavirus loans
Proceeds from exercise of options
Proceeds from common over-allotment
Proceeds from warrants over-allotment
Payment of stock issuance costs
Proceeds from (repayments to) convertible notes payable
(Repayments to) proceeds from line of credit
Repayments of notes payable
Acquisition of issued common stock held in treasury
Payments on finance lease liabilities
Proceeds from exercise of warrants
Gross proceeds from common stock offering January 2022
Gross proceeds from common stock offering December 2022
Capital contribution of non-controlling interest
Net cash (used in) provided by financing activities
Net decrease in cash
Cash beginning of year
Cash end of year

Effect of exchange rate on cash
Reconciliation of net loss to cash flow used by operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense
Change in allowance for credit losses
Change in inventory reserve
Intangible asset amortization
Amortization of right-of-use assets - operating leases
Amortization of right-of-use assets - finance leases
Write-off of digital assets
Amortization of debt discount, net
Write-off of right-of-use asset
Impairment loss
Healthcare Operations
Total impairment loss
Equity in net loss of affiliate
Stock-based compensation in connection with restricted stock awards
Stock-based compensation in connection with options granted
Gain on debt extinguishment
Stock-based compensation
Gain on sale or disposal of property and equipment
Loss (gain) on sale or disposal of property and equipment

Change in operating assets and liabilities:
Accounts receivable
Inventories
Unbilled revenue
Prepaid expense
Notes receivable
Other assets
Deposits
VAT receivable
Accounts payable and accrued expenses
Provision for income taxes
Operating lease liabilities
Income taxes payable
Contract liabilities
Liabilities from discontinued operations
Net cash used in operating activities

Comments